Login / Signup

Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats.

Il Gyu KoLakkyong HwangJun-Jang JinSang-Hoon KimJin-Hee HanJung Won JeonSung Tae Cho
Published in: International neurourology journal (2018)
Combination therapy of tamsulosin and naftopidil showed greater efficacy for the treatment of BPH than tamsulosin monotherapy or naftopidil monotherapy; therefore, combination therapy can be considered as a novel therapeutic method for BPH.
Keyphrases
  • combination therapy
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • clinical trial
  • stem cells
  • angiotensin converting enzyme
  • blood brain barrier
  • angiotensin ii
  • smoking cessation